ATLAS fair value
ATLAS has no fair value for this stock today.
Thor Medical stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Oslo Børs · Norway
Prices as of Oct 27, 2026 · NOK
ATLAS has no fair value for this stock today.
47%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Thor Medical a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between NOK 3.73 and NOK 4.69; in 9 out of 10, between NOK 3.05 and NOK 5.74. Estimated annual volatility is 60%.
ATLAS does not publish a fair value for TRMED.OL right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks TRMED.OL has traded between NOK 3.31 and NOK 7.12. Today it is 40.5% below that high and 28% above its low.
Its beta is -0.01: it tends to move less than the market.
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
Want to see everything about Thor Medical?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
47%: close to a coin flip. In half of the simulated outcomes, TRMED.OL ends the month between NOK 3.73 and NOK 4.69.
Thor Medical's market capitalization is NOK 1.8B. We do not show a P/E because it has no positive earnings to base one on.
ATLAS estimates annual volatility at 60%. In a typical month, half of the outcomes end between NOK 3.73 and NOK 4.69.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy